Predictive Oncology Inc (NASDAQ:POAI) shares are trading higher by 46.6% to $2.30 during Tuesday’s session after the company announced positive results from a retrospective study conducted with UPMC ...
POAI ‘s Helomics Division Announces Progress on Milestones for its AI-Driven Model of Ovarian Cancer
MINNEAPOLIS, Feb. 24, 2021 (GLOBE NEWSWIRE) -- Predictive Oncology (NASDAQ: POAI), a knowledge-driven company focused on applying artificial intelligence (“AI”) to personalized medicine and drug ...
Predictive Oncology Inc., a knowledge and science-driven company, applies artificial intelligence (AI) to support the discovery and development of cancer therapies. It operates through two segments, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results